Farzad Gheshlaghi
1,2*1 Department of Clinical Toxicology and Forensic Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
*Corresponding Author: *Corresponding author: Dr. Farzad Gheshlaghi, Clinical Toxicology Department, Nour Medical Center, Isfahan, Iran. Telephone: 0098311-2222127, Fax:0098311-2222255, Email:
Implication for health policy/practice/research/medical education:
Recently, several cases of poisoning following the different drug poisoning have been referred to our emergency department with more severe conditions that different and more intense in contrast to cases have been reported previously. These patients nearly almost died despite ICU care. Due to not-so-long-term toxicity it appears that another mechanisms than mentioned before are involved in the occurrence and progression of this syndrome. In order to figure out the causes of this syndrome future studies are recommended.
Please cite this paper as: Gheshlaghi F. Malignant drug-induced rhabdomyolysis. J Nephropathology. 2012; 1(1): 59-60. DOI: 10.5812/jnp.11